Expanding horizons to cure muscle-invasive bladder cancer: A novel treatment algorithm.
作者信息
Agrawal Shashank
机构信息
Department of Uro-oncology, Sindhu Hospital, Hyderabad, Telangana, India.
出版信息
Indian J Urol. 2025 Apr-Jun;41(2):153-154. doi: 10.4103/iju.iju_501_24. Epub 2025 Apr 1.
Abstract
摘要
相似文献
1
Expanding horizons to cure muscle-invasive bladder cancer: A novel treatment algorithm.
Indian J Urol. 2025 Apr-Jun;41(2):153-154. doi: 10.4103/iju.iju_501_24. Epub 2025 Apr 1.
2
Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT.
Health Technol Assess. 2022 Oct;26(40):1-144. doi: 10.3310/PLPU1526.
3
Contemporary management of muscle-invasive bladder cancer.
Int J Clin Oncol. 2008 Dec;13(6):504-9. doi: 10.1007/s10147-008-0788-9. Epub 2008 Dec 18.
4
Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec.
Eur Urol Oncol. 2025 Apr;8(2):425-434. doi: 10.1016/j.euo.2024.09.016. Epub 2024 Oct 15.
5
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance.
Curr Urol Rep. 2025 Apr 10;26(1):36. doi: 10.1007/s11934-025-01264-6.
6
Challenges in the treatment of bladder cancer.
Ann Oncol. 2006 May;17 Suppl 5:v106-12. doi: 10.1093/annonc/mdj963.
7
The Efficacy and Safety of Hyperthermia Intravesical Chemotherapy in the Treatment of Non-Muscle-Invasive Bladder Cancer: A Meta-Analysis.
Urol Int. 2024;108(4):322-333. doi: 10.1159/000538373. Epub 2024 Mar 20.
8
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer.
Semin Radiat Oncol. 2023 Jan;33(1):21-25. doi: 10.1016/j.semradonc.2022.10.003.
9
[Muscle invasive bladder cancer and bladder preservation protocols. Where are we?].
Arch Esp Urol. 2020 Dec;73(10):986-995.
10
BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer.
Curr Oncol. 2024 Feb 16;31(2):1063-1078. doi: 10.3390/curroncol31020079.
本文引用的文献
1
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
N Engl J Med. 2024 Nov 14;391(19):1773-1786. doi: 10.1056/NEJMoa2408154. Epub 2024 Sep 15.
2
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.
N Engl J Med. 2025 Jan 2;392(1):45-55. doi: 10.1056/NEJMoa2401726. Epub 2024 Sep 15.
3
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17.
J Clin Oncol. 2023 Nov 20;41(33):5131-5139. doi: 10.1200/JCO.23.00363. Epub 2023 Aug 17.
4
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial.
Clin Cancer Res. 2022 Dec 1;28(23):5107-5114. doi: 10.1158/1078-0432.CCR-22-2158.
5
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
N Engl J Med. 2021 Jun 3;384(22):2102-2114. doi: 10.1056/NEJMoa2034442.
Zotero 插件